Bone Marrow Radiation Shielding Act

Don Bacon

Republican · NE · Representative

Source: Congress.gov · FEC

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Referred to the House Committee on Armed Services.

2026-09-17

Source: Congress.gov

Plain-English summary pending. Introduced on 2026-09-17. Check back soon — summaries are generated as bills progress through Congress.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 10483 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 10483 To direct the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense, Policy and Programs to seek to enter into an agreement with a University Affiliated Research Center affiliated with United States Strategic Command to conduct an independent scientific assessment with respect to bone marrow radiation shielding for nuclear survivability. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES September 17, 2026 Mr. Bacon introduced the following bill; which was referred to the Committee on Armed Services _______________________________________________________________________ A BILL To direct the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense, Policy and Programs to seek to enter into an agreement with a University Affiliated Research Center affiliated with United States Strategic Command to conduct an independent scientific assessment with respect to bone marrow radiation shielding for nuclear survivability. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Bone Marrow Radiation Shielding Act''. SEC. 2. INDEPENDENT ASSESSMENT OF BONE MARROW RADIATION SHIELDING FOR NUCLEAR SURVIVABILITY. (a) Assessment Required.--Not later than 30 days after the date of the enactment of this Act, the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense, Policy and Programs shall seek to enter into an agreement with a University Affiliated Research Center affiliated with United States Strategic Command to conduct an independent scientific assessment on whether preserving the viability of bone marrow using partial body radiation shielding can improve the survivability of an individual exposed to gamma radiation as compared to an individual without such protection. (b) Elements.--The assessment required under subsection (a) shall examine peer-reviewed scientific literature, laboratory studies and relevant experimental data to evaluate the comparative effectiveness of preserving bone marrow using partial body radiation shielding with respect to-- (1) the likelihood of developing Acute Radiation Syndrome; (2) the severity of Acute Radiation Syndrome when it occurs; and (3) overall mortality rates following gamma radiation exposure. (c) Report.--Not later than 150 days after the date of the enactment of this Act, the Assistant Secretary shall submit to the Committees on Armed Services of the House of Representatives and the Senate a report on the assessment required under subsection (a) that includes the findings of such assessment. <all>

• HR10482Dashboard for MILCON Projects Act
  Referred to Committee · 2026-09-17
• HR10480Medal of Honor Access and Liaison Act
  Referred to Committee · 2026-09-17
• HR10485Minuteman III Health and Safety Act
  Referred to Committee · 2026-09-17
• HR10479Quantum Benchmark Act
  Referred to Committee · 2026-09-17